Literature DB >> 24468088

Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy.

Hao Bao1, Shuai Hu1, Changming Zhang1, Shaolin Shi1, Weisong Qin1, Caihong Zeng1, Ke Zen1, Zhihong Liu2.   

Abstract

Podocytopathy and tubular interstitial fibrosis impact on renal outcomes of IgA nephropathy (IgAN). We found that level of miR-21 was up regulated in both glomerular and tubular-interstitial tissues of patients with IgAN. Enhanced expression of miR-21 mainly located in podocytes and tubular cells. Mesangial cell derived cytokines contributed to the increase of miR-21 in podocytes and HK2 cells. IgA-HMC medium prepared with pIgA from IgAN, lead to obvious fibrogenic activation, evidenced by the loss of Podocin and CD2AP in podocytes, loss of E-cadherin and Megalin in HK2 cells and increase of FN and Col I in both cells. miR-21 targeted PTEN in these cells. Expression of PTEN was decreased and phosphorylation of Akt was increased in podocytes and HK2 cells exposed to the medium prepared with pIgA from IgAN. Inhibition of miR-21 preserved the expression of PTEN, prevented the activation of Akt and inhibited the fibrogenic activation in podocytes and HK2 cells exposed to the IgA-HMC medium prepared with pIgA from IgAN. In conclusion, our study suggests that inhibition of miR-21 prevents fibrogenic activation in podocytes and tubular cells by preventing PTEN/Akt pathway activation in IgAN.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibrogenic activation; IgA nephropathy; miRNA-21

Mesh:

Substances:

Year:  2014        PMID: 24468088     DOI: 10.1016/j.bbrc.2014.01.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

Review 2.  Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

Authors:  Wenshan Lv; Fan Fan; Yangang Wang; Ezekiel Gonzalez-Fernandez; Chen Wang; Lili Yang; George W Booz; Richard J Roman
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

3.  Emerging role of miRNAs in renal fibrosis.

Authors:  Youling Fan; Hongtao Chen; Zhenxing Huang; Hong Zheng; Jun Zhou
Journal:  RNA Biol       Date:  2019-09-24       Impact factor: 4.652

4.  Decreased miR-128 and increased miR-21 synergistically cause podocyte injury in sepsis.

Authors:  Shanshan Wang; Jun Wang; Zengdi Zhang; Hongjun Miao
Journal:  J Nephrol       Date:  2017-05-11       Impact factor: 3.902

Review 5.  Novel Biomarkers of Kidney Disease in Advanced Heart Failure: Beyond GFR and Proteinuria.

Authors:  Bethany Roehm; Meredith McAdams; S Susan Hedayati
Journal:  Curr Heart Fail Rep       Date:  2022-05-28

6.  Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423.

Authors:  Mira Pavkovic; Cassianne Robinson-Cohen; Alicia S Chua; Oana Nicoara; Mariana Cárdenas-González; Vanesa Bijol; Krithika Ramachandran; Lucy Hampson; Munir Pirmohamed; Daniel J Antoine; Gyorgy Frendl; Jonathan Himmelfarb; Sushrut S Waikar; Vishal S Vaidya
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

7.  The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.

Authors:  Shuai Hu; Runhong Han; Jingsong Shi; Xiaodong Zhu; Weisong Qin; Caihong Zeng; Hao Bao; Zhihong Liu
Journal:  J Biol Chem       Date:  2018-11-02       Impact factor: 5.157

8.  Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy.

Authors:  Clemens L Bockmeyer; Karen Säuberlich; Juliane Wittig; Marc Eßer; Sebastian S Roeder; Udo Vester; Peter F Hoyer; Putri A Agustian; Philip Zeuschner; Kerstin Amann; Christoph Daniel; Jan U Becker
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

Review 9.  The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021?

Authors:  Izabella Z A Pawluczyk; Haresh Selvaskandan; Jonathan Barratt
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

10.  miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.

Authors:  Marie-Flore Hennino; David Buob; Cynthia Van der Hauwaert; Viviane Gnemmi; Zacharie Jomaa; Nicolas Pottier; Grégoire Savary; Elodie Drumez; Christian Noël; Christelle Cauffiez; François Glowacki
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.